← Back to Discover
Spruce Street Capital LP
Period ended Sep 30, 2026 · Latest filing Nov 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $628,983,538
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- KINIKSA PHARMACEUTICALS INTL · ORD SHS CL A · G52694109 · shares: $68,497,203
- LB PHARMACEUTICALS INC · COM SHS · 50180M108 · shares: $53,863,456
- RELAY THERAPEUTICS INC · COM · 75943R102 · shares: $53,863,456
- ALTO NEUROSCIENCE INC · COM SHS · 02157Q109 · shares: $42,802,526
- ALKERMES PLC · SHS · G01767105 · shares: $38,432,045
- ENTERA BIO LTD · SHS · M40527109 · shares: $32,631,154
- DIANTHUS THERAPEUTICS INC · COM · 252828108 · shares: $31,241,549
- SAVARA INC · COM · 805111101 · shares: $27,770,816
- ZAI LAB LTD · ADR · 98887Q104 · shares: $27,450,442
- RELMADA THERAPEUTICS INC · COM · 75955J402 · shares: $26,058,960
Reported holdings
39 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | — | 918,070 shares | $68,497,203 |
| LB PHARMACEUTICALS INC | COM SHS | 50180M108 | — | 1,404,779 shares | $53,863,456 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 2,984,125 shares | $53,863,456 |
| ALTO NEUROSCIENCE INC | COM SHS | 02157Q109 | — | 1,676,558 shares | $42,802,526 |
| ALKERMES PLC | SHS | G01767105 | — | 948,471 shares | $38,432,045 |
| ENTERA BIO LTD | SHS | M40527109 | — | 11,213,455 shares | $32,631,154 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 354,816 shares | $31,241,549 |
| SAVARA INC | COM | 805111101 | — | 5,381,941 shares | $27,770,816 |
| ZAI LAB LTD | ADR | 98887Q104 | — | 1,042,158 shares | $27,450,442 |
| RELMADA THERAPEUTICS INC | COM | 75955J402 | — | 6,912,191 shares | $26,058,960 |
| VAXCYTE INC | COM | 92243G108 | — | 306,047 shares | $17,414,074 |
| OBSIDIAN THERAPEUTICS INC | COM | 67448A106 | — | 1,249,943 shares | $17,161,717 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 329,006 shares | $15,081,635 |
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | — | 1,088,731 shares | $14,349,475 |
| SURROZEN INC | COM NEW | 86889P208 | — | 432,040 shares | $13,903,047 |
| SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | — | 1,400,000 shares | $13,832,000 |
| YARROW BIOSCIENCE INC | COM | 92941V407 | — | 607,382 shares | $13,678,243 |
| INFLARX NV | COM | N44821101 | — | 6,086,170 shares | $10,955,106 |
| KORSANA BIOSCIENCES INC | COM | 23255M303 | — | 338,951 shares | $10,304,110 |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | — | 3,693,931 shares | $10,158,310 |
| AN2 THERAPEUTICS INC | COM | 037326105 | — | 1,752,011 shares | $9,320,699 |
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | — | 3,581,603 shares | $7,360,194 |
| SAB BIOTHERAPEUTICS INC | COM NEW | 78397T202 | — | 2,198,502 shares | $6,969,251 |
| CENTURY THERAPEUTICS INC | COM | 15673T100 | — | 4,059,054 shares | $6,940,982 |
| ERASCA INC | COM | 29479A108 | — | 422,543 shares | $6,194,480 |
| ACHIEVE LIFE SCIENCE INC | COM | 004468500 | — | 736,637 shares | $5,959,393 |
| MINERVA NEUROSCIENCES INC | COM NEW | 603380205 | — | 1,655,500 shares | $5,545,925 |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | G75226103 | — | 500,000 shares | $5,415,000 |
| RESEARCH ALLIANCE CORP IV | CL A ORD SHS | G75228109 | — | 450,000 shares | $5,400,000 |
| HELIX ACQUISITION CORP III | USD CL A ORD SHS | G4444S107 | — | 500,000 shares | $5,310,000 |
| ATTOVIA THERAPEUTICS INC | COM | 04987L102 | — | 228,295 shares | $3,912,976 |
| ALECTOR INC | COM | 014442107 | — | 2,101,068 shares | $3,886,976 |
| TCGX ACQUISITION CORP | ORD CL A | G8708J109 | — | 300,000 shares | $3,753,000 |
| LEXEO THERAPEUTICS INC | COM | 52886X107 | — | 928,593 shares | $3,138,644 |
| ALUMIS INC | COM | 022307102 | — | 392,574 shares | $2,901,122 |
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | — | 231,585 shares | $2,667,859 |
| JATT II ACQUISITION CORP | ORD SHS | G50765109 | — | 160,000 shares | $1,799,200 |
| JATT III ACQUISITION CORP | ORD SHS | G5080G109 | — | 150,000 shares | $1,653,000 |
| LEONABIO INC | COM | 04746L203 | — | 393,701 shares | $1,405,513 |